期刊文献+

小儿多发性抽动症遗传学易感因素的关联分析研究 被引量:3

Association analysis study of genetics predisposing factor in multiple tics
下载PDF
导出
摘要 目的研究小儿多发性抽动症的遗传学易感因素,了解儿茶酚氧位甲基转移酶(COMT)基因在小儿多发性抽动症发病中的作用,探讨小儿多发性抽动症的病因及其治疗机制。方法采用病例对照研究,COMT基因定型采用聚合酶链反应扩增、限制性片段长度多态性分析,用SPSS软件进行统计学处理。结果COMT基因型和正常对照间有显著性差异(P<0.01)。结论小儿多发性抽动症患者COMT基因区域多态性有明显改变,患者Met等位基因型比例下降,Val等位基因型比例升高,提示小儿多发性抽动症患者的发病因素与COMT基因多态性变化引起酶活性下降,从而导致多巴胺系统的缺陷相关。 Objective It is to study the genetics predisposing factor of multiple tics (MT), to understand the role of catechol-o-methyltransferas (COMT) gene in the onset of MT and to discuss the etiological factor of MT and its therapy mechanism, Methods The case control study was used, COMT genotyping was analyzed with polymerase chain reaction (PCR) followed by restriction fragment length polymorphism (RFLP). Statistical analysis was performed with SPSS software. Results There was significant difference between COMT genotype of MT patients and healthy controls (P〈 0.01 ), Conclusion The polymorphism in the region of COMT gene in MT patients has obvious changes, The proportion of Met allele genotype of MT patients lower and the proportion of Val allele genotype rose. It explains that the etiological factor of MT re- lates to the polymorphism change of COMT gene causing enzymatic activity lowering and thereby inducing the defect of dopamine system.
出处 《现代中西医结合杂志》 CAS 2007年第29期4261-4263,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 多发性抽动症 多巴胺 儿茶酚氧位甲基转移酶基因 multiple tics Dopamine catechol-o-methyltransferas gene
  • 相关文献

参考文献7

  • 1杨宏宇,皇甫恩,谭庆荣.抽动-秽语综合征的遗传学研究进展[J].国外医学(精神病学分册),2001,28(4):238-242. 被引量:3
  • 2周永红,宋国维,唐勇.小儿抽动症临床辨治[J].四川中医,2003,21(7):10-11. 被引量:7
  • 3张骠.小儿多发性抽动症中医证治特点及其研究述略[J].江苏中医药,2004,25(9):1-3. 被引量:47
  • 4Wong D,Brasic J,Singer H,et al.PET imaging of dopamine and serotonin in Tourette's Syndrome[J].neuroimage,2006,31(4):162
  • 5Grandy DK,Marchioni MA,Makam H,et al.Cloning of the cDNA and gene for ahuman 132 dopamine receptor[J].Proc Natl Sci USA,1989,86(24):9762-9766
  • 6Tao Li,Homero V,David C,et al.Catechol-o-methyltransferase Val 158 Met polymorphism frequency analysis in han Chinese sunjects and allelic association of the lew activity allele with bipolar affective disorder[J].Pharmacogenetics,1997,7(5):349-353
  • 7Singer HS.Neurobiolngy of Tourette syndrome[J].Neurol Clin,1997,15(2):357-79

二级参考文献21

  • 1[1]刘智胜.小儿多发性抽动症.第1版.北京:人民卫生出版社,2004:17
  • 2Ohta S, Sakuragawa N. Tissue - plasminogen activator (t - PA). Nippon Rinsho, 1999, 57 Suppl ( - HD - ): 671 - 675
  • 3Dietzmann K, von BossanyiP, KrauseD, et al. Expression oftheplasminogen activator system and the inhibitors PAI - 1 and PAI - 2 in posttraumatic lesions of the CNS and brain injuries following dramatic circulatory arrests: an immunohistochemical study. Pathol Res Pract, 2000,196(1): 15-21
  • 4Mimuro J. Plasminogen activator inhibitor 1 (PAI - 1 ). Nippon Rinsho, 1999, 57 Suppl ( - HD - ): 678 - 681
  • 5Baumeister FA, Auberger K, Schneider K. Thrombosis of the deep cerebral veins with excessive bilateral infarction in a premature infant with the thrombogenic 4G/4G genotype of the plasminogen activator inhibitor- 1. Eur J Pediatr, 2000, 159(4): 239 - 242
  • 6Lindgren A, Lindoff C, Norrving B, et al. Tissue plasminogen activator and plasminogen activator inhibitor- 1 in stroke patients. Stroke, 1996,27(6): 1066 - 1071
  • 7Hayashi T. Tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI). Rinsho Byori, 1994, 42(4): 346-351
  • 8C atto AJ, Carter AM, Stickland M, et al. Plasminogen activator inhibitor- 1 (PAI - 1) 4G/5G promoter polymorphism and levels in subjects with cerebrovascular disease. Thromb Haemost, 1997, 77(4):730 - 734
  • 9Wakamatsu S, Banno T, Tohnai M, et al. Changes of the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor- 1 in cerebral infarction induced by the venous occlusion. Nippon Ronen Igakkai Zasshi, 1995, 32(8 - 9): 566 - 570
  • 10Zunker P, Schick A, Padr T, et al. Tissue plasminogen activator and plasminogen activator inhibitor in patients with acute ischemic stroke:relation to stroke etiology. Neurol Res, 1999, 21(8): 727-732

共引文献53

同被引文献62

  • 1汪受传,虞坚尔.中医儿科学[M].北京:中国中医药出版社,2012:84-90.
  • 2朱丹溪.格致余论局方发挥[M].北京:中国医药科技出版社,2011:50-51.
  • 3SteevesT D,Fox S H.Neurobiological basis of serotonindopamine antag-onists in the treatment of Gilles dela Tourette syndrome [J].Prog Brain Res,2008(172):495.
  • 4KenneyC,Kuo S H,Jimenez Shahed J.Tourette^s syndrome [J].Am FamPhysician,2008,77(5):651.
  • 5AlibinR L.Resent advances in Tourettes^ syndrome research [Jj.TendsNeurosci, 2006,29( 3) : 178.
  • 6KeenKim D, Freimer N B.Genetics and epidemiology of Tourette syn-drome[J].Child Neurol,2006,21(8):665-671.
  • 7KenneyC,Kuo S H,Jimenez Shahed J.Tourette's syndrome [J].Am FamPhysician,2008,77(5):651.
  • 8LawsonYuen A,Saldivar J S,Sommer S,et al.Familial deletion withinNLGN4 associated with autism and Tourette syndrome [J].Eur J HumGenet,2008,16(5):614.
  • 9AckermansL,Temel Y, Visser Vandewalle V.Deep brain stimulation inTourette's syndrome[J].Neurotherapeutics,2008,5(2):339.
  • 10AlibinR L.Resent advances in Tourettes' syndrome research [Jj.TendsNeurosci,2006,29(3):178 .

引证文献3

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部